MDxHealth (MDXH) Raw Materials (2023 - 2025)

MDxHealth has disclosed Raw Materials across 3 years of filings, most recently posting $6.9 million for Q4 2025.

• Raw Materials for Q4 2025 came in at $6.9 million, up 78.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.9 million (up 78.26% YoY), and the FY2025 annual result was $6.9 million, up 78.26% from the prior year.
• Raw Materials came in at $6.9 million for Q4 2025 at MDxHealth, up from $3.9 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $6.9 million in Q4 2025 to a low of $2.8 million in Q4 2023.
• The 3-year median for Raw Materials is $3.9 million (2024), against an average of $4.5 million.
• Across the five-year window, Raw Materials surged 39.22% in 2024 and soared 78.26% in 2025, its largest moves.
• MDxHealth's Raw Materials stood at $2.8 million in 2023, then soared by 39.22% to $3.9 million in 2024, then jumped by 78.26% to $6.9 million in 2025.
• The last three Raw Materials figures came in at $6.9 million (Q4 2025), $3.9 million (Q4 2024), and $2.8 million (Q4 2023), per Business Quant data.